公开(公告)号：EP4294369A1

公开(公告)日：2023-12-27

申请号：EP22774463.8

申请日：2022-03-23

申请人： Samjin Pharmaceutical Co., Ltd. ,  Aptabio Therapeutics Inc.

发明人： KI, Min-Hyo ,  KIM, Jin-cheul ,  CHOI, Mee-Hwa ,  LEE, Dong-Ha ,  MOON, Sung Hwan ,  LEE, Soo Jin

IPC分类号： A61K9/00 ,  A61K47/20 ,  A61K31/4439 ,  A61P27/02

公开(公告)号：EP4052694A1

公开(公告)日：2022-09-07

申请号：EP20888845.3

申请日：2020-11-20

申请人： Samjin Pharmaceutical Co., Ltd. ,  Aptabio Therapeutics Inc.

发明人： KI, Min-hyo ,  KIM, Jin-cheul ,  CHOI, Mee-Hwa ,  LEE, Dong-Ha ,  MOON, Sung Hwan ,  LEE, Soo Jin

IPC分类号： A61K9/00 ,  A61K9/08 ,  A61K47/10 ,  A61K47/12 ,  A61K47/40 ,  A61K31/4439 ,  A61P27/02

摘要： The present invention relates to an ophthalmic preparation containing an active ingredient selected from 3-phenyl-4-propyl-1-(pyridin-2-yl)-1H-pyrazol-5-ol compound or a pharmaceutically acceptable salt thereof. The eye drop according to the present invention is excellent in stability and safety and shows an excellent effect on prevention or treatment of eye diseases in such a way that an active ingredient thereof reaches a posterior segment of an eyeball simply through instillation rather than a direct injection into an eyeball.

公开(公告)号：EP3976034A1

公开(公告)日：2022-04-06

申请号：EP20813160.7

申请日：2020-05-29

申请人： Samjin Pharmaceutical Co., Ltd. ,  Aptabio Therapeutics Inc.

发明人： KI, Min-hyo ,  NAM, Kyung-wan ,  KIM, Jin-cheul ,  AHN, Kyung-jin ,  MOON, Sung Hwan ,  LEE, Soo Jin

IPC分类号： A61K31/4439 ,  A61K9/00 ,  A61K47/34 ,  A61K47/02 ,  A61K47/42 ,  A61K47/36 ,  A61P27/02